Streetbeat News

Stock Prices

ACER

AKAN

APLT

AXLA

CDTX

HSDT

LGVNR

NBSE

NSTG

PALI

PAVM

RVLP

During Wednesday's intraday session, several healthcare stocks experienced significant movements. Gainers included NeuBase Therapeutics (NBSE), Palisade Bio (PALI), Applied Therapeutics (APLT), Cidara Therapeutics (CDTX), Akanda (AKAN), and PAVmed (PAVM). Losers included Longeveron Inc. - Subscription Right (LGVNR), RVL Pharmaceuticals (RVLP), Helius Medical Tech (HSDT), NanoString Technologies (NSTG), Axcella Health (AXLA), and Acer Therapeutics (ACER).

Portfolio Pulse from Benzinga Insights

September 06, 2023 | 5:31 pm

AGFY

AULT

AVAV

CVEO

DSS

EFSH

ELIQ

EOSE

GTEC

HLGN

HYFM

During Wednesday's intraday session, several industrials stocks experienced significant movements. AeroVironment (NASDAQ:AVAV), Greenland Technologies (NASDAQ:GTEC), Civeo (NYSE:CVEO), Agrify (NASDAQ:AGFY), DSS (AMEX:DSS), and Electriq Power Holdings (NYSE:ELIQ) saw their shares increase, while Heliogen (NYSE:HLGN), 1847 Holdings (AMEX:EFSH), Eos Energy Enterprises (NASDAQ:EOSE), Wheels Up Experience (NYSE:UP), Hydrofarm Holdings Group (NASDAQ:HYFM), and Ault Alliance (AMEX:AULT) experienced a decrease in their stock prices.

Portfolio Pulse from Benzinga Insights

September 06, 2023 | 5:31 pm

FOXO

HKIT

MRIN

VERB

During Wednesday's intraday session, several information technology stocks experienced significant movements. Marin Software (MRIN), FOXO Technologies (FOXO), Mitek Systems (MITK), T Stamp (IDAI), VerifyMe (VRME), and Minim (MINM) saw their shares increase, with Marin Software leading the gainers with a 42.3% rise. On the other hand, Hitek Global (HKIT), Verb Tech (VERB), Akoustis Technologies (AKTS), CXApp (CXAI), WM Tech (MAPS), and Asana (ASAN) experienced declines in their share prices, with Hitek Global leading the losers with a 50.9% drop.

Portfolio Pulse from Benzinga Insights

September 06, 2023 | 5:31 pm

WW International shares are trading higher despite no company-specific news.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 5:30 pm

TMUS

T-Mobile's CEO has announced a $19 billion share buyback program that will run through the end of 2024. The announcement was made at a Goldman Sachs conference.

Portfolio Pulse from Happy Mohamed

September 06, 2023 | 5:28 pm

RVYL

RYVYL Inc. has announced a 1-for-10 reverse stock split of its common stock, which is expected to become effective on September 6, 2023. The move aims to increase the market price per share to maintain compliance with the $1.00 minimum bid price required for continued listing on The Nasdaq Capital Market and to make investments in the company more attractive. Post-split, the number of outstanding shares will reduce from approximately 52.4 million to 5.24 million.

Portfolio Pulse from Happy Mohamed

September 06, 2023 | 5:22 pm

WIX

Analysts from JMP Securities and Benchmark reiterated their positive outlook on Wix.com Ltd (NASDAQ:WIX), with a price target of $130. They believe Wix can sustain low-teens growth driven by Partners and see potential for increased efficiency with AI integration. Wix's management is confident in achieving FY25 targets and expects GAAP operating profitability by the second half of FY24. Wix shares are currently trading higher by 1.64%.

Portfolio Pulse from Anusuya Lahiri

September 06, 2023 | 5:20 pm

DNLI

B. Riley Securities has initiated coverage on Denali Therapeutics with a Buy rating and a price target of $38. This has led to an increase in the trading of Denali Therapeutics shares.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 5:19 pm

TSLA

Tesla's Model Y continues to lead the EV SUV market, but Ford's Mustang Mach-E has seen a strong rebound in sales, ranking second in August. Ford's sales were up 61.3% YoY with 5,033 units sold in August. However, year-to-date sales are down 10.7% YoY. Ford's F-150 Lightning sales dropped by 57.1% in August due to a factory shutdown. Ford's Q2 revenue for its EV segment was $1.8 billion, up 39% YoY. Ford's shares are down 2.03% to $11.84.

Portfolio Pulse from Chris Katje

September 06, 2023 | 5:19 pm

ASND

Ascendis Pharma reported a Q2 earnings beat and entered a royalty funding agreement with Royalty Pharma, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 5:18 pm